AG˹ٷ

STOCK TITAN

[144] Insmed, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Insmed, Inc. (INSM) reported a Form 144 notice showing an insider intends to sell 13,600 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,654,338.00 and an approximate sale date of 08/13/2025. The shares were acquired in two restricted-stock vesting events: 5,942 shares on 05/15/2019 and 7,658 shares on 05/12/2021, both listed as consideration for services rendered. The filing also discloses a prior sale by the same person of 25,000 shares on 06/10/2025 for gross proceeds of $2,180,846.00.

The notice states the filer represents they have no undisclosed material adverse information about the issuer. Outstanding shares are shown as 211,374,786, which provides context for the scale of these transactions versus total shares outstanding.

Insmed, Inc. (INSM) ha presentato un avviso Form 144 che segnala l'intenzione di un insider di vendere 13.600 azioni ordinarie tramite Morgan Stanley Smith Barney LLC, per un valore di mercato complessivo di $1,654,338.00 e con data approssimativa di vendita 08/13/2025. Le azioni erano state acquisite in due eventi di vesting di azioni soggette a restrizioni: 5.942 azioni il 05/15/2019 e 7.658 azioni il 05/12/2021, entrambe indicate come corrispettivo per prestazioni di servizi. La documentazione segnala inoltre una vendita precedente da parte della stessa persona di 25.000 azioni il 06/10/2025 per proventi lordi di $2,180,846.00.

L'avviso dichiara che il dichiarante rappresenta di non avere informazioni materiali avverse non divulgate sull'emittente. Le azioni in circolazione sono indicate in 211,374,786, dato che contestualizza l'entità di queste operazioni rispetto al totale delle azioni in circolazione.

Insmed, Inc. (INSM) presentó un aviso Form 144 en el que se indica que un insider tiene la intención de vender 13,600 acciones ordinarias a través de Morgan Stanley Smith Barney LLC, con un valor de mercado agregado de $1,654,338.00 y una fecha aproximada de venta 08/13/2025. Las acciones se adquirieron en dos eventos de vesting de acciones restringidas: 5,942 acciones el 05/15/2019 y 7,658 acciones el 05/12/2021, ambas indicadas como contraprestación por servicios prestados. La presentación también revela una venta previa por parte de la misma persona de 25,000 acciones el 06/10/2025 por ingresos brutos de $2,180,846.00.

El aviso señala que el declarante afirma no poseer información adversa material no divulgada sobre el emisor. Las acciones en circulación se muestran en 211,374,786, lo que ofrece contexto sobre la magnitud de estas transacciones en relación con el total de acciones en circulación.

Insmed, Inc. (INSM)은 내부자가 Morgan Stanley Smith Barney LLC� 통해 보통� 13,600주를 매도� 의사가 있음� 알리� Form 144 통지서를 제출했으�, � 시장 가치는 $1,654,338.00이고 예상 매각일은 08/13/2025� 기재되어 있습니다. 해당 주식은 � 차례� 제한� 베스�(vesting)에서 취득� 것으�, 5,942주는 05/15/2019�, 7,658주는 05/12/2021� 각각 서비� 제공� 대� 대가� 부여되었습니다. 제출서류� 또한 동일인이 06/10/2025� 25,000주를 이전� 매도하여 총수� $2,180,846.00� 얻었다고 밝히� 있습니다.

통지서에� 제출인이 발행회사� 관� 공개되지 않은 중대� 불리� 정보� 보유하고 있지 않다� 진술하고 있습니다. 유통주식 수는 211,374,786주로 표시되어 이번 거래 규모가 전체 발행주식 대� 어느 정도인지� 대� 맥락� 제공합니�.

Insmed, Inc. (INSM) a déposé un avis Form 144 indiquant qu'un initié a l'intention de vendre 13 600 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney LLC, pour une valeur marchande totale de $1,654,338.00 et une date approximative de vente au 08/13/2025. Les actions ont été acquises lors de deux événements de vesting d'actions restreintes : 5 942 actions le 05/15/2019 et 7 658 actions le 05/12/2021, toutes deux indiquées comme contrepartie pour des services rendus. Le dépôt révèle également qu'une vente antérieure par la même personne de 25 000 actions a eu lieu le 06/10/2025 pour des produits bruts de $2,180,846.00.

L'avis précise que le déclarant affirme ne détenir aucune information défavorable importante non divulguée concernant l'émetteur. Le nombre d'actions en circulation est indiqué à 211,374,786, ce qui permet de situer l'ampleur de ces opérations par rapport au total des actions en circulation.

Insmed, Inc. (INSM) hat ein Form-144-Schreiben eingereicht, das aussagt, dass ein Insider beabsichtigt, 13.600 Stammaktien über Morgan Stanley Smith Barney LLC zu veräußern; der aggregierte Marktwert beträgt $1,654,338.00 und das voraussichtliche Verkaufsdatum ist der 08/13/2025. Die Aktien wurden in zwei Restricted-Stock-Vesting-Ereignissen erworben: 5.942 Aktien am 05/15/2019 und 7.658 Aktien am 05/12/2021, jeweils als Gegenleistung für erbrachte Dienstleistungen angegeben. Die Einreichung gibt außerdem an, dass dieselbe Person am 06/10/2025 bereits 25.000 Aktien verkauft hat und daraus Bruttoerlöse von $2,180,846.00 erzielte.

In der Mitteilung erklärt der Einreicher, dass er keine nicht offengelegten, wesentlichen nachteiligen Informationen über den Emittenten besitzt. Die ausstehenden Aktien werden mit 211,374,786 angegeben, was die Größenordnung dieser Transaktionen im Verhältnis zur Gesamtzahl der ausstehenden Aktien einordnet.

Positive
  • None.
Negative
  • Insider sale scheduled: 13,600 common shares with an aggregate market value of $1,654,338.00 and approximate sale date 08/13/2025.
  • Recent prior sale: The filer sold 25,000 shares on 06/10/2025 for $2,180,846.00, indicating multiple recent insider dispositions.

Insights

TL;DR: Insider sales totaling 38,600 shares recently, but size is small relative to 211.4M shares outstanding; impact appears limited.

The Form 144 shows an intended sale of 13,600 shares valued at $1,654,338.00 on 08/13/2025 and a prior sale of 25,000 shares on 06/10/2025 for $2,180,846.00. Both the shares to be sold were acquired via restricted stock vesting for services in 2019 and 2021. Relative to the issuer's reported 211,374,786 shares outstanding, these sales represent a small fraction of the float, suggesting limited immediate market impact. Investors should note the factual presence of insider selling but the transaction sizes do not by themselves indicate a material change to company capitalization.

TL;DR: Insider disposal of vested restricted shares is disclosed; pattern of recent sales is noteworthy for governance transparency.

The filing documents that restricted stock vesting (05/15/2019 and 05/12/2021) produced the 13,600 shares to be sold through Morgan Stanley Smith Barney LLC, and records a recent sale of 25,000 shares on 06/10/2025. These disclosures comply with Rule 144 reporting and include the filer’s attestation of no undisclosed material adverse information. From a governance standpoint, transparent reporting of the transactions and the broker used supports regulatory compliance; the sequential sales are relevant to monitoring insider trading behavior but, standing alone, are routine dispositions of vested compensation.

Insmed, Inc. (INSM) ha presentato un avviso Form 144 che segnala l'intenzione di un insider di vendere 13.600 azioni ordinarie tramite Morgan Stanley Smith Barney LLC, per un valore di mercato complessivo di $1,654,338.00 e con data approssimativa di vendita 08/13/2025. Le azioni erano state acquisite in due eventi di vesting di azioni soggette a restrizioni: 5.942 azioni il 05/15/2019 e 7.658 azioni il 05/12/2021, entrambe indicate come corrispettivo per prestazioni di servizi. La documentazione segnala inoltre una vendita precedente da parte della stessa persona di 25.000 azioni il 06/10/2025 per proventi lordi di $2,180,846.00.

L'avviso dichiara che il dichiarante rappresenta di non avere informazioni materiali avverse non divulgate sull'emittente. Le azioni in circolazione sono indicate in 211,374,786, dato che contestualizza l'entità di queste operazioni rispetto al totale delle azioni in circolazione.

Insmed, Inc. (INSM) presentó un aviso Form 144 en el que se indica que un insider tiene la intención de vender 13,600 acciones ordinarias a través de Morgan Stanley Smith Barney LLC, con un valor de mercado agregado de $1,654,338.00 y una fecha aproximada de venta 08/13/2025. Las acciones se adquirieron en dos eventos de vesting de acciones restringidas: 5,942 acciones el 05/15/2019 y 7,658 acciones el 05/12/2021, ambas indicadas como contraprestación por servicios prestados. La presentación también revela una venta previa por parte de la misma persona de 25,000 acciones el 06/10/2025 por ingresos brutos de $2,180,846.00.

El aviso señala que el declarante afirma no poseer información adversa material no divulgada sobre el emisor. Las acciones en circulación se muestran en 211,374,786, lo que ofrece contexto sobre la magnitud de estas transacciones en relación con el total de acciones en circulación.

Insmed, Inc. (INSM)은 내부자가 Morgan Stanley Smith Barney LLC� 통해 보통� 13,600주를 매도� 의사가 있음� 알리� Form 144 통지서를 제출했으�, � 시장 가치는 $1,654,338.00이고 예상 매각일은 08/13/2025� 기재되어 있습니다. 해당 주식은 � 차례� 제한� 베스�(vesting)에서 취득� 것으�, 5,942주는 05/15/2019�, 7,658주는 05/12/2021� 각각 서비� 제공� 대� 대가� 부여되었습니다. 제출서류� 또한 동일인이 06/10/2025� 25,000주를 이전� 매도하여 총수� $2,180,846.00� 얻었다고 밝히� 있습니다.

통지서에� 제출인이 발행회사� 관� 공개되지 않은 중대� 불리� 정보� 보유하고 있지 않다� 진술하고 있습니다. 유통주식 수는 211,374,786주로 표시되어 이번 거래 규모가 전체 발행주식 대� 어느 정도인지� 대� 맥락� 제공합니�.

Insmed, Inc. (INSM) a déposé un avis Form 144 indiquant qu'un initié a l'intention de vendre 13 600 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney LLC, pour une valeur marchande totale de $1,654,338.00 et une date approximative de vente au 08/13/2025. Les actions ont été acquises lors de deux événements de vesting d'actions restreintes : 5 942 actions le 05/15/2019 et 7 658 actions le 05/12/2021, toutes deux indiquées comme contrepartie pour des services rendus. Le dépôt révèle également qu'une vente antérieure par la même personne de 25 000 actions a eu lieu le 06/10/2025 pour des produits bruts de $2,180,846.00.

L'avis précise que le déclarant affirme ne détenir aucune information défavorable importante non divulguée concernant l'émetteur. Le nombre d'actions en circulation est indiqué à 211,374,786, ce qui permet de situer l'ampleur de ces opérations par rapport au total des actions en circulation.

Insmed, Inc. (INSM) hat ein Form-144-Schreiben eingereicht, das aussagt, dass ein Insider beabsichtigt, 13.600 Stammaktien über Morgan Stanley Smith Barney LLC zu veräußern; der aggregierte Marktwert beträgt $1,654,338.00 und das voraussichtliche Verkaufsdatum ist der 08/13/2025. Die Aktien wurden in zwei Restricted-Stock-Vesting-Ereignissen erworben: 5.942 Aktien am 05/15/2019 und 7.658 Aktien am 05/12/2021, jeweils als Gegenleistung für erbrachte Dienstleistungen angegeben. Die Einreichung gibt außerdem an, dass dieselbe Person am 06/10/2025 bereits 25.000 Aktien verkauft hat und daraus Bruttoerlöse von $2,180,846.00 erzielte.

In der Mitteilung erklärt der Einreicher, dass er keine nicht offengelegten, wesentlichen nachteiligen Informationen über den Emittenten besitzt. Die ausstehenden Aktien werden mit 211,374,786 angegeben, was die Größenordnung dieser Transaktionen im Verhältnis zur Gesamtzahl der ausstehenden Aktien einordnet.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does INSM's Form 144 disclose about the planned sale?

The filing discloses an intended sale of 13,600 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $1,654,338.00 and an approximate sale date of 08/13/2025.

How were the shares being sold by the insider acquired?

The shares were acquired via restricted stock vesting: 5,942 shares on 05/15/2019 and 7,658 shares on 05/12/2021, listed as consideration for services rendered.

Has the same person sold shares recently?

Yes. The filing lists a prior sale by the same person of 25,000 shares on 06/10/2025 for gross proceeds of $2,180,846.00.

What is the issuer’s reported share count for context?

The document reports 211,374,786 shares outstanding, which provides scale for the disclosed transactions.

Which broker is handling the proposed sale?

The proposed sale is through Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza, New York, NY 10004 as listed).
Insmed Inc

NASDAQ:INSM

INSM Rankings

INSM Latest News

INSM Latest SEC Filings

INSM Stock Data

23.86B
208.96M
0.75%
110.41%
5.1%
Biotechnology
Pharmaceutical Preparations
United States
BRIDGEWATER